Franklin Resources Inc Novo Nordisk A S Transaction History

Franklin Resources Inc

  • $313 Billion
  • Q2 2024

A detailed history of Franklin Resources Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Franklin Resources Inc holds 880,247 shares of NVO stock, worth $121 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
880,247
Previous 619,968 41.98%
Holding current value
$121 Million
Previous $79.6 Million 57.84%
% of portfolio
0.04%
Previous 0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$122.71 - $146.91 $31.9 Million - $38.2 Million
260,279 Added 41.98%
880,247 $126 Million
Q1 2024

May 13, 2024
BUY
$102.11 - $135.92 $7.64 Million - $10.2 Million
74,850 Added 13.73%
619,968 $79.6 Million
Q4 2023

Feb 09, 2024
SELL
$87.78 - $105.45 $203,649 - $244,644
-2,320 Reduced 0.42%
545,118 $56.4 Million
Q3 2023

Nov 13, 2023
BUY
$90.94 - $199.54 $23.3 Million - $51.1 Million
255,979 Added 87.83%
547,438 $49.8 Million
Q2 2023

Aug 11, 2023
SELL
$155.98 - $172.65 $2.89 Million - $3.19 Million
-18,500 Reduced 5.97%
291,459 $47.2 Million
Q1 2023

May 12, 2023
SELL
$132.34 - $159.14 $1.62 Million - $1.95 Million
-12,235 Reduced 3.8%
309,959 $49.3 Million
Q4 2022

Feb 10, 2023
SELL
$102.55 - $135.33 $271,347 - $358,083
-2,646 Reduced 0.81%
322,194 $43.6 Million
Q3 2022

Nov 14, 2022
SELL
$95.28 - $116.93 $155,401 - $190,712
-1,631 Reduced 0.5%
324,840 $32.4 Million
Q2 2022

Aug 11, 2022
SELL
$103.24 - $121.81 $1.7 Million - $2 Million
-16,426 Reduced 4.79%
326,471 $36.4 Million
Q1 2022

May 13, 2022
SELL
$93.1 - $112.54 $934,165 - $1.13 Million
-10,034 Reduced 2.84%
342,897 $38.1 Million
Q4 2021

Feb 11, 2022
SELL
$95.88 - $117.08 $365,111 - $445,840
-3,808 Reduced 1.07%
352,931 $39.5 Million
Q3 2021

Nov 12, 2021
SELL
$84.42 - $106.62 $685,659 - $865,967
-8,122 Reduced 2.23%
356,739 $34.3 Million
Q2 2021

Aug 13, 2021
SELL
$67.66 - $84.76 $1.18 Million - $1.47 Million
-17,374 Reduced 4.55%
364,861 $30.6 Million
Q1 2021

May 13, 2021
BUY
$67.06 - $75.82 $1.06 Million - $1.19 Million
15,733 Added 4.29%
382,235 $25.8 Million
Q4 2020

Feb 10, 2021
BUY
$63.89 - $73.8 $9.53 Million - $11 Million
149,197 Added 68.66%
366,502 $25.6 Million
Q3 2020

Nov 12, 2020
SELL
$63.69 - $70.22 $4.09 Million - $4.51 Million
-64,164 Reduced 22.8%
217,305 $15.1 Million
Q2 2020

Aug 13, 2020
SELL
$58.54 - $67.94 $1.13 Million - $1.31 Million
-19,321 Reduced 6.42%
281,469 $19.3 Million
Q1 2020

May 13, 2020
SELL
$49.46 - $64.78 $415,958 - $544,799
-8,410 Reduced 2.72%
300,790 $18.1 Million
Q4 2019

Feb 12, 2020
SELL
$49.86 - $58.26 $1.52 Million - $1.78 Million
-30,585 Reduced 9.0%
309,200 $17.9 Million
Q3 2019

Nov 14, 2019
SELL
$47.54 - $53.43 $1.84 Million - $2.06 Million
-38,628 Reduced 10.21%
339,785 $17.6 Million
Q2 2019

Aug 14, 2019
SELL
$46.79 - $52.47 $1.69 Million - $1.89 Million
-36,042 Reduced 8.7%
378,413 $19.3 Million
Q1 2019

May 14, 2019
SELL
$46.36 - $52.63 $2.17 Million - $2.46 Million
-46,713 Reduced 10.13%
414,455 $21.7 Million
Q4 2018

Feb 12, 2019
SELL
$41.54 - $47.25 $729,317 - $829,568
-17,557 Reduced 3.67%
461,168 $21.2 Million
Q3 2018

Nov 13, 2018
SELL
$46.76 - $51.24 $480,271 - $526,286
-10,271 Reduced 2.1%
478,725 $22.6 Million
Q2 2018

Aug 14, 2018
SELL
$44.29 - $50.42 $1.97 Million - $2.25 Million
-44,570 Reduced 8.35%
488,996 $22.6 Million
Q1 2018

May 10, 2018
SELL
$48.49 - $58.14 $2.5 Million - $2.99 Million
-51,460 Reduced 8.8%
533,566 $26.3 Million
Q4 2017

Feb 14, 2018
SELL
$47.53 - $53.73 $3.39 Million - $3.84 Million
-71,420 Reduced 10.88%
585,026 $31.4 Million
Q3 2017

Nov 13, 2017
BUY
$41.15 - $49.22 $27 Million - $32.3 Million
656,446
656,446 $31.6 Million

Others Institutions Holding NVO

# of Institutions
1,990
Shares Held
318M
Call Options Held
5.23M
Put Options Held
4.97M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $309B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email